首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1523252

荷爾蒙避孕藥市場報告：2030 年趨勢、預測與競爭分析

Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2024年07月01日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

荷爾蒙避孕藥的趨勢和預測

到 2030 年，全球荷爾蒙避孕藥市場預計將達到 198 億美元，2024 年至 2030 年複合年成長率為 3.8%。該市場的主要驅動力是新興經濟體對荷爾蒙避孕方法的認知不斷提高，以及領先公司對新型避孕設備研發的投資激增。全球荷爾蒙避孕藥市場的未來看起來充滿希望，荷爾蒙避孕藥市場和純黃體素市場都充滿機會。

荷爾蒙避孕藥細分市場

該研究包括按方法、荷爾蒙和地區對全球荷爾蒙避孕藥的預測。

荷爾蒙避孕藥市場洞察

Lucintel 預測，由於人們對藥物的認知不斷增強，藥物在預測期內仍將是最大的細分市場。

在這個市場中，CHC 將繼續成為更大的細分市場。

由於目標人口眾多且主要企業的投資不斷增加，預計亞太地區在預測期內將出現最高的成長。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球荷爾蒙避孕藥市場預計將達到 198 億美元。

Q2.市場成長預測是多少：

A2. 預計 2024 年至 2030 年全球荷爾蒙避孕藥市場將以 3.8% 的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要促進因素是新興經濟體對荷爾蒙避孕方法的認知不斷提高，以及大公司對新型避孕器具研發的投資激增。

Q4.市場的主要細分市場是：

A4. 荷爾蒙避孕藥市場前景廣闊，CHC 市場和純黃體素市場都有機會。

Q5.市場的主要企業是：

A5. 主要的荷爾蒙避孕藥公司如下：

AbbVie
Afaxys
Teva Pharmaceuticals Industries
Bayer
Organon
Pfizer
Agile Therapeutics
Janssen Pharmaceutical
Lupin Pharmaceutical
Pregna International

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於人們對藥物的認知不斷增強，藥物在預測期內仍將是其最大的細分市場。

Q7.未來五年預計哪個地區的市場成長最大？

由於目標人口龐大且主要企業不斷增加投資，A7.APAC預計將在預測期內實現最高成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

The future of the global hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets. The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030 with a CAGR of 3.8% from 2024 to 2030. The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Hormonal Contraceptive by Segment

The study includes a forecast for the global hormonal contraceptive by method, hormone, and region.

Hormonal Contraceptive Market by Method [Shipment Analysis by Value from 2018 to 2030]:

Pill
Intrauterine Device
Injectable
Vaginal Ring
Implant
Patch

Hormonal Contraceptive Market by Hormone [Shipment Analysis by Value from 2018 to 2030]:

Combination Hormonal Contraceptive
Progestin Only

Hormonal Contraceptive Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Hormonal Contraceptive Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hormonal contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hormonal contraceptive companies profiled in this report include-

AbbVie
Afaxys
Teva Pharmaceuticals Industries
Bayer
Organon
Pfizer
Agile Therapeutics
Janssen Pharmaceutical
Lupin Pharmaceutical
Pregna International

Hormonal Contraceptive Market Insights

Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Within this market, combination hormonal contraceptive will remain larger segment.

APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Features of the Global Hormonal Contraceptive Market

Market Size Estimates: Hormonal contraceptive market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Hormonal contraceptive market size by method, hormone, and region in terms of value ($B).

Regional Analysis: Hormonal contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different methods, hormones, and regions for the hormonal contraceptive market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hormonal contraceptive market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the hormonal contraceptive market size?

Answer: The global hormonal contraceptive market is expected to reach an estimated $19.8 billion by 2030.

Q2. What is the growth forecast for hormonal contraceptive market?

Answer: The global hormonal contraceptive market is expected to grow with a CAGR of 3.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the hormonal contraceptive market?

Answer: The major drivers for this market are growing awareness regarding hormonal contraception method in emerging economies and surge in investments by the major players for the R&D of novel contraceptive devices.

Q4. What are the major segments for hormonal contraceptive market?

Answer: The future of the hormonal contraceptive market looks promising with opportunities in the combination hormonal contraceptive and progestin only markets.

Q5. Who are the key hormonal contraceptive market companies?

Answer: Some of the key hormonal contraceptive companies are as follows:

AbbVie
Afaxys
Teva Pharmaceuticals Industries
Bayer
Organon
Pfizer
Agile Therapeutics
Janssen Pharmaceutical
Lupin Pharmaceutical
Pregna International

Q6. Which hormonal contraceptive market segment will be the largest in future?

Answer: Lucintel forecasts that pill will remain the largest segment over the forecast period due to increasing awareness about the pills.

Q7. In hormonal contraceptive market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness the highest growth over the forecast period due to presence of large pool target population and rise in investment by key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the hormonal contraceptive market by method (pill, intrauterine device, injectable, vaginal ring, implant, and patch), hormone (combination hormonal contraceptive and progestin only), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Hormonal Contraceptive Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Hormonal Contraceptive Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Hormonal Contraceptive Market by Method
- 3.3.1: Pill
- 3.3.2: Intrauterine Device
- 3.3.3: Injectable
- 3.3.4: Vaginal Ring
- 3.3.5: Implant
3.4: Global Hormonal Contraceptive Market by Hormone
- 3.4.1: Combination Hormonal Contraceptive
- 3.4.2: Progestin Only

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Hormonal Contraceptive Market by Region
4.2: North American Hormonal Contraceptive Market
- 4.2.1: North American Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
- 4.2.2: North American Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.3: European Hormonal Contraceptive Market
- 4.3.1: European Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
- 4.3.2: European Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.4: APAC Hormonal Contraceptive Market
- 4.4.1: APAC Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
- 4.4.2: APAC Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only
4.5: ROW Hormonal Contraceptive Market
- 4.5.1: ROW Hormonal Contraceptive Market by Method: Pill, Intrauterine Device, Injectable, Vaginal Ring, Implant, and Patch
- 4.5.2: ROW Hormonal Contraceptive Market by Hormone: Combination Hormonal Contraceptive and Progestin Only

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Hormonal Contraceptive Market by Method
- 6.1.2: Growth Opportunities for the Global Hormonal Contraceptive Market by Hormone
- 6.1.3: Growth Opportunities for the Global Hormonal Contraceptive Market by Region
6.2: Emerging Trends in the Global Hormonal Contraceptive Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Hormonal Contraceptive Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Hormonal Contraceptive Market
- 6.3.4: Certification and Licensing